AHA Scientific Sessions 2025 Abstract
Immunogenicity of Recaticimab Does Not Impact Its Efficacy in Patients with Dyslipidemia: A Pooled Analysis of Three Phase III and One Phase Ib/II Studies
Trial in peopleInterventions
Papers by Zhen-Yue Chen
1 result